Richard Klausner, Director at Lyell Immunopharma, Inc. (LYEL), bought 158,000 shares at $0.60 ($95K) on 2025-03-14, disclosed to the SEC on 2025-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| JUNO | SELL | 2018-01-09 | $1.2M | — | Filing → |
| JUNO | SELL | 2017-12-22 | $3.2M | — | Filing → |
| JUNO | SELL | 2017-09-08 | $1.0M | — | Filing → |